Frequency of Celiac Disease in Children with Beta Thalassemia Major

Overview

Journal Iran J Ped Hematol Oncol

Specialty Pediatrics

Date 2014 Jul 9

PMID 25002924

Citations 2

Authors

N Honar

S Kamali

M Karimi

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to investigate the frequency of celiac disease in children with β-thalassemia major (B-TM) in Shiraz, southern Iran.

Materials And Methods: In this study, the prevalence of celiac disease in children with B-TM was evaluated. Children with B-TM were screened for celiac disease by ant-tissue transglutaminase (anti-tTG) IgA antibody, IgA level and anti-tTG IgG. A total of 1500 school healthy children in Shiraz with age/sex matched were selected as control group.

Results: A total of 215 B-TM patients with mean age of 12.7 ± 4.4 years, were included into the study (52.1% was male). None of the patients were positive for anti-tTG IgA. Eight cases were IgA deficient in whom anti-tTG IgG was investigated but none of them were positive for anti-tTG IgG. The finding in control group has a seroprevalence of 2% and biopsy proven disease of 0.6%.

Conclusion: Many patients with thalassemia major have multiple non specific symptom that are not justifiable with underlying disease and might be due to atypical celiac disease. We didn't find any case of celiac disease among more than 200 children with β-thalassemia major in Shiraz, southern Iran. So it seems reasonable to screen only those who have features, even not classical, of celiac disease.

Citing Articles

Celiac disease in Iran: a systematic review and meta-analysis.

Mohammadibakhsh R, Sohrabi R, Salemi M, Taheri Mirghaed M, Behzadifar M Electron Physician. 2017; 9(3):3883-3895.

PMID: 28461861 PMC: 5407219. DOI: 10.19082/3883.

Serologic evaluation of celiac disease in patients with beta thalassemia major and control.

Shahramian I, Dehghani S, Haghighat M, Noori N, Teimouri A, Sharafi E Gastroenterol Hepatol Bed Bench. 2015; 8(2):153-9.

PMID: 25926941 PMC: 4403028.

References

Borgna-Pignatti C, Gamberini M . Complications of thalassemia major and their treatment. Expert Rev Hematol. 2011; 4(3):353-66. DOI: 10.1586/ehm.11.29. View

Fasano A, Berti I, Gerarduzzi T, Not T, Colletti R, Drago S . Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003; 163(3):286-92. DOI: 10.1001/archinte.163.3.286. View

Tack G, Verbeek W, Schreurs M, Mulder C . The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol. 2010; 7(4):204-13. DOI: 10.1038/nrgastro.2010.23. View

Emami M, Karimi S, Kouhestani S, Hashemi M, Taheri H . Diagnostic accuracy of IgA anti-tissue transglutaminase in patients suspected of having coeliac disease in Iran. J Gastrointestin Liver Dis. 2008; 17(2):141-6. View

Mulder C, Bartelsman J . Case-finding in coeliac disease should be intensified. Best Pract Res Clin Gastroenterol. 2005; 19(3):479-86. DOI: 10.1016/j.bpg.2005.01.007. View

Skordis N, Kyriakou A . The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev. 2011; 8 Suppl 2:271-7. View

Acquaviva A, Municchi G, Marconcini S, DAmbrosio A, Morgese G . Celiac disease in a patient with beta-thalassemia major. J Pediatr Gastroenterol Nutr. 2003; 36(4):489-91. DOI: 10.1097/00005176-200304000-00014. View

Camarca M, Mozzillo E, Nugnes R, Zito E, Falco M, Fattorusso V . Celiac disease in type 1 diabetes mellitus. Ital J Pediatr. 2012; 38:10. PMC: 3348012. DOI: 10.1186/1824-7288-38-10. View

Dehghani S, Haghighat M, Mobayen A, Rezaianzadeh A, Geramizadeh B . Prevalence of celiac disease in healthy Iranian school children. Ann Saudi Med. 2013; 33(2):159-61. PMC: 6078606. DOI: 10.5144/0256-4947.2013.159. View

10.

Moayeri H, Oloomi Z . Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Arch Iran Med. 2006; 9(4):329-34. View

11.

Mangiagli A, Campisi S . [Celiac disease associated with major thalassemia. A case report]. Minerva Pediatr. 1996; 48(9):401-5. View

12.

Saneian H, Gorgani A . Diagnostic value of serologic tests in celiac screening. Int J Prev Med. 2012; 3(Suppl 1):S58-63. PMC: 3399307. View

13.

Rostami Nejad M, Rostami K, Emami M, Zali M, Malekzadeh R . Epidemiology of celiac disease in iran: a review. Middle East J Dig Dis. 2014; 3(1):5-12. PMC: 4154929. View

14.

Parakh A, Sudha S, Dubey A, Gupta A . Celiac disease in a child with beta-thalassemia major: a need for improved screening and awareness. J Pediatr Hematol Oncol. 2009; 30(12):913-4. DOI: 10.1097/MPH.0b013e31817541f6. View

15.

Fasano A, Catassi C . Clinical practice. Celiac disease. N Engl J Med. 2012; 367(25):2419-26. DOI: 10.1056/NEJMcp1113994. View

16.

Chng C, Jones M, Kingham J . Celiac disease and autoimmune thyroid disease. Clin Med Res. 2007; 5(3):184-92. PMC: 2111403. DOI: 10.3121/cmr.2007.738. View

17.

Toumba M, Sergis A, Kanaris C, Skordis N . Endocrine complications in patients with Thalassaemia Major. Pediatr Endocrinol Rev. 2007; 5(2):642-8. View

18.

Husby S, Koletzko S, Korponay-Szabo I, Mearin M, Phillips A, Shamir R . European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2011; 54(1):136-60. DOI: 10.1097/MPG.0b013e31821a23d0. View